Metagenomi Therapeutics, Inc 10-Q for FY2026 Q2
Metagenomi Therapeutics, Inc. (MGX)
10-Q
2026-08-10
For: 2026-06-30
View Original
Added on
August 10, 2026
About this 10-Q
Metagenomi Therapeutics, Inc filed this 10-Q on August 10, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $27.48M
- compared with a net loss of $19.91M a year earlier
- Diluted EPS
- -$0.73
- compared with -$0.54 a year earlier